(Riya Singh, Intern Journalist): Astra-Zeneca, a global biopharmaceutical company, is expected to soon announce breakthrough results on its pursuit of a COVID-19 vaccine. The research supporting this COVID-19 vaccine breakthrough involves brains from Oxford University-all spearheaded by a university professor of vaccinology Sarah Catherine Gilbert.
The Oxford COVID-19 vaccine is also being developed and mass-produced by the Serum India Institute located in Pune, with funding from Indian ICMR. In April 2020, they had announced that the Oxford COVID-19 vaccine they are testing should be ready by September and sold at 1000 Rs per vaccine.
AstraZeneca is already mass-producing two billion doses of the vaccine candidate Oxford COVID-19, technically known as ChAdOx1 nCoV-19. Sarah Gilbert has a crucial role to play in it as this was helped by her expertise and her past work around the coronavirus.
By the end of April, Oxford had started clinical trials of its vaccine candidates on 1,100 people. The vaccine development phase was a mere four months. The teams had reached the final stages of human testing by June end and now AstraZeneca is reportedly due to announce the positive results in the near future. Once that happens, the vaccine will be in production by September.
About Post Author
